Genomic Valley Biotech Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹0 Cr
QMarch 2025
Quarterly Results

In 2026, Genomic Valley Biotech (GVBL) reported revenue ₹1 Cr and net profit ₹0 Cr. For annual financials, live price and key ratios, visit GVBL screener.

GVBL Quarterly Results — Revenue, Profit & EPS Highlights

Genomic Valley Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore GVBL stock price history to track price trends across different timeframes.

  • Revenue of ₹1 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 52.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹1.17 in March 2025 (+0.0% vs March 2025)

Genomic Valley Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

GVBL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 1 1 0 3 0 - -
Net Profit (₹ Cr) 0 0 0 1 0 - -
EBITDA (₹ Cr) 0 0 0 1 0 - -
EPS (₹) -0.20 1.17 0.05 2.12 -0.03 - -
Operating Margin (%) 13.0% 52.0% 9.0% 32.0% -535.0% - -

GVBL Share Price Trend — 1-Year Movement Across Quarterly Results

Genomic Valley Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with GVBL DCF valuation to assess whether the stock is under or overvalued.

Profitability Ratios

Operating Margin 52.0%

Balance Sheet Highlights

Total Assets ₹4 Cr
Total Equity ₹4 Cr
Current Assets ₹3 Cr
Current Liabilities ₹0 Cr

Cash Flow Analysis

Operating Cash Flow ₹0 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹0 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹26.54
Exchange BSE
Last Updated May 25, 2026

GVBL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Genomic Valley Biotech latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026
₹442,581.33 Cr 1844.3 15,018 2,710 +1.0% +11.8% 18.0% 163.2
Divis Laboratories
Mar 2026
₹179,363.85 Cr 6797.5 2,986 751 +4.4% +11.8% 25.2% 240.1
Torrent Pharmaceuti…
Mar 2026
₹153,579.77 Cr 4537.8 4,111 364 +27.7% +42.2% 8.9% 394.2
Cipla
Mar 2026
₹114,559.46 Cr 1418.2 6,612 543 -14.3% -4.0% 8.2% 206.4
Dr Reddys Laborator…
Mar 2026
₹110,089.41 Cr 1319.0 7,996 221 -12.5% -11.5% 2.8% 497.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores